29.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
5-year MS study: BRIUMVI patients average one relapse every 50 years - Stock Titan
Liquidity Mapping Around (TGTX) Price Events - Stock Traders Daily
Portfolio Shifts: Should you avoid TG Therapeutics Inc stock right now2025 Investor Takeaways & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
TG Therapeutics, Inc. (TGTX) Stock Analysis: A 55.89% Potential Upside in the Biotech Space - DirectorsTalk Interviews
What are TG Therapeutics Inc.’s recent SEC filings showingMarket Performance Summary & Free Long-Term Investment Growth Plans - mfd.ru
What are TG Therapeutics Inc.’s growth leversJuly 2025 Technicals & Weekly Chart Analysis and Trade Guides - mfd.ru
TG Therapeutics, Inc. $TGTX Shares Bought by Public Sector Pension Investment Board - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Downgraded by Wall Street Zen to "Hold" - MarketBeat
What is TG Therapeutics Inc.’s valuation compared to sectorJuly 2025 Opening Moves & Verified Momentum Stock Ideas - mfd.ru
TGTX Stock Price, Forecast & Analysis | TG THERAPEUTICS INC (NASDAQ:TGTX) - ChartMill
Goldman Sachs Raises TG Therapeutics, Inc. (TGTX) Target to $39 on 2026 Guidance - Insider Monkey
TGTX News Today | Why did TG Therapeutics stock go down today? $TGTX - MarketBeat
Should you avoid TG Therapeutics Inc. stock right now2025 Sector Review & Free Risk Controlled Daily Trade Plans - mfd.ru
Why TG Therapeutics Inc. (NKB2) stock gets analyst attentionTrade Entry Report & Community Supported Trade Ideas - mfd.ru
10 Best Long Term Healthcare Stocks to Buy - Insider Monkey
TG Therapeutics (TGTX) sees price target drop from JPMorgan - MSN
Should New BRIUMVI Data and MS Campaign Shift TG Therapeutics' (TGTX) Narrative on Commercial Execution? - Yahoo Finance
TG Therapeutics lights up Super Bowl with Christina Applegate MS campaign — retail sees 'huge win' - MSN
TG Therapeutics Lights Up Super Bowl With Christina Applegate MS Campaign — Retail Sees 'Huge Win' - Stocktwits
MSFT Vs AMZN Vs GOOGL: Which Cloud Stock Is A Better Bet? - Stocktwits
TG Therapeutics Announces Collaboration with Christina Applegate to Raise Awareness of Multiple Sclerosis - GlobeNewswire
Christina Applegate fronts new MS honesty campaign with TG Therapeutics - Stock Titan
TG Therapeutics Partners with Christina Applegate to Raise MS Awareness - intellectia.ai
TG Therapeutics (TGTX) Sees Price Target Drop from JPMorgan - Finviz
TG Therapeutics presents BRIUMVI data at ACTRIMS forum By Investing.com - Investing.com Nigeria
TG Therapeutics stock pops as Briumvi boom reignites bull case: Goldman Sachs sees room for 32% rally - MSN
TG Therapeutics Presents BRIUMVI Data at ACTRIMS Annual Meeting - Intellectia AI
TG Therapeutics presents BRIUMVI data at ACTRIMS forum - Investing.com
TG Therapeutics rises on new data for autoimmune therapy - TradingView
TG Therapeutics Presents New Data on BRIUMVI® at ACTRIMS 2026 Annual Forum - Quiver Quantitative
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum - The Manila Times
Real-world and pediatric MS data put BRIUMVI under spotlight at ACTRIMS - Stock Titan
Aug Intraday: Is TG Therapeutics Inc a turnaround story2025 Institutional Moves & AI Driven Stock Movement Reports - baoquankhu1.vn
Why (TGTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
TG Therapeutics (NASDAQ:TGTX) Takes On Some Risk With Its Use Of Debt - 富途牛牛
TG Therapeutics stock maintains Buy rating at B.Riley on strong Briumvi growth - Investing.com Canada
Hussman Strategic Advisors Sells 126,000 TG Therapeutics Shares - AOL.com
JP Morgan Adjusts Price Target for TGTX, Maintains Overweight Ra - GuruFocus
JPMorgan Chase & Co. Issues Pessimistic Forecast for TG Therapeutics (NASDAQ:TGTX) Stock Price - MarketBeat
TG Therapeutics, Inc. (TGTX) Investor Outlook: Exploring the 52.42% Potential Upside and Strategic Positioning in Biotechnology - DirectorsTalk Interviews
Quarterly Trades: Will TG Therapeutics Inc benefit from AI trendsWeekly Gains Report & Fast Momentum Entry Tips - baoquankhu1.vn
Universal Beteiligungs und Servicegesellschaft mbH Has $2.29 Million Stake in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics Readies New BRIUMVI Data As Market Weighs Valuation - Sahm
Assessing TG Therapeutics (TGTX) Valuation After Recent Share Price Weakness And BRIUMVI Growth Assumptions - Yahoo Finance
TG Therapeutics to present BRIUMVI data at ACTRIMS forum By Investing.com - Investing.com Canada
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):